Capstone Wealth Management Group (Oregon)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Sell
5,389
-5,637
-51% -$1.31M 0.82% 32
2026
Q1
$2.7M Buy
11,026
+14
+0.1% +$3.26K 1.66% 19
2025
Q4
$2.28M Hold
11,012
1.38% 24
2025
Q3
$2.04M Buy
11,012
+273
+3% +$46.8K 1.3% 24
2025
Q2
$1.64M Buy
10,739
+118
+1% +$18.1K 1.19% 27
2025
Q1
$1.76M Buy
10,621
+221
+2% +$34.6K 1.41% 23
2024
Q4
$1.5M Buy
+10,400
New +$1.61M 1.14% 27

Other funds holding JNJ

Capstone Wealth Management Group (Oregon)'s JNJ Position: Q2 2026 in Review

Capstone Wealth Management Group (Oregon) reduced its Johnson & Johnson (JNJ) stake by 51% in Q2 2026, selling an estimated $1.31M and leaving 5,389 shares worth $1.37M. The position accounts for 0.82% of the portfolio, ranked #32.

Capstone Wealth Management Group (Oregon) first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.7M in Q1 2026. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Capstone Wealth Management Group (Oregon) held 5,389 shares of Johnson & Johnson worth $1.37M as of Q2 2026.
  • Capstone Wealth Management Group (Oregon) sold 5,637 Johnson & Johnson shares in Q2 2026, an estimated $1.31M.
  • Johnson & Johnson made up 0.82% of Capstone Wealth Management Group (Oregon)'s portfolio in Q2 2026, its #32 holding.
  • Capstone Wealth Management Group (Oregon) first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • Capstone Wealth Management Group (Oregon)'s Johnson & Johnson position peaked at $2.7M in Q1 2026.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Capstone Wealth Management Group (Oregon)'s 13F filing for Q2 2026, filed 27 Jul 2026.